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Background and purpose 11 
Knee extensor (KE) muscle weakness is a modifiable feature commonly observed in individuals with 12 
knee osteoarthritis (KOA) and constitute a potential target for patient specific interventions.  13 
Therefore, in this study, we explored whether KE weakness is associated with radiographic (medial 14 
and/or lateral) KOA progression and how this relationship differs depending on frontal plane knee 15 
alignment and sex. 16 
Methods 17 
We studied 3,075 knees (1,961 participants, 58% female) from the Osteoarthritis Initiative with 18 
radiographic Kellgren/Lawrence grade 1-3. Peak KE torque (Nm/kg) was assessed at baseline, and 19 
progression defined as fixed-location joint space width loss (≥0.7mm) in medial and lateral 20 
tibiofemoral compartments from baseline to 4-year follow-up. Knee-based generalized estimating 21 
equations, stratified by alignment (malaligned vs. neutral), estimated the relative risk (RR) of 22 
progression for those in the lowest (and middle) vs. highest KE torque group (split by tertiles). 23 
Secondary analyses explored whether this relationship was compartmental- or sex-specific.  24 
Results 25 
Being in the lowest (or middle) compared with the highest torque group increased the risk of 26 
progression in neutrally aligned knees (relative risk [RR] 1.2 [95%CI 1.0, 1.4]; and 1.2 [95%CI 1.0, 1.4], 27 
respectively), but not after adjusting for age, sex, body mass index (BMI), pain and radiographic 28 
severity. In secondary analyses, women with neutral alignment in the lowest compared to the 29 
highest torque group had significantly increased risk of lateral compartment progression 30 
independent of age, BMI, disease severity and pain (RR 1.3 [95%CI 1.0, 1.8]). No association was 31 





These results identify a potentially important clinical phenotype – KE weakness may be a more 34 





Knee extensor (KE) muscle weakness is a modifiable feature commonly observed in individuals with 37 
knee osteoarthritis (KOA) and a risk factor for incident radiographic KOA (Øiestad et al. 2015). In 38 
terms of disease progression, the relationship between KE weakness and radiographic KOA is less 39 
clear, perhaps due to an apparent sex-specific effect whereby women (but not men) with muscle 40 
weakness have an increased risk of KOA progression (Culvenor et al. 2017b). 41 
Frontal plane knee alignment, an independent risk factor for KOA, has been reported to represent a 42 
potential confounder in the sex-specific relationship between KE weakness and KOA progression 43 
(Sharma et al. 2003). Contradictory to the concept of KE weakness increasing the risk of KOA 44 
progression, Sharma et al. (2003), in a study of 171 participants (328 knees), observed that greater 45 
KE torque increased the risk of radiographic KOA progression in individuals with established KOA and 46 
knee malalignment. These data provide preliminary evidence that the relationship between KE 47 
torque and disease progression depends on the local mechanical environment, where malalignment 48 
may determine how the medial and lateral tibiofemoral joint responds to muscle force. However, 49 
contradictory longitudinal MRI data in 265 older adults with KOA (mean age 67 years) subsequently 50 
showed that KE weakness did not influence medial and lateral compartment cartilage loss in either 51 
aligned or malaligned knees, but without accounting for previously observed differences in men and 52 
women (Amin et al. 2009). 53 
Insights into the alignment- and sex--specific impact of KE weakness on medial and lateral KOA 54 
progression may be of value for developing personalized treatment strategies. Therefore, we 55 
determined whether the relationship between lower KE torque and risk of radiographic disease 56 
progression depends on knee alignment in a large cohort of >3,000 knees, and whether this 57 
relationship is compartment- and sex-specific. Based on previous data, we hypothesized that 58 
alignment modifies the relationship between KE torque and risk of radiographic progression and that 59 







Participants were selected from the Osteoarthritis Initiative (OAI, http://www.oai.ucsf.edu), an 64 
ongoing multicentre cohort study designed to identify biomarkers and risk factors associated with 65 
KOA incidence and progression. The OAI includes 4,796 participants, aged 45-79 years, with, or at 66 
risk of, symptomatic KOA. For the current study, we included knees with radiographic 67 
Kellgren/Lawrence (KL) grade 1-3 at baseline (central reading release 0.7). Knees without any 68 
radiographic evidence of OA (KL 0) were excluded as the current analysis focuses specifically on 69 
disease progression. Knees with end-stage disease (KL 4) were excluded due to having a limited 70 
capacity to progress. Eligible knees were those with KE strength, alignment (radiographic femur-tibia 71 
angle [FTA]) at baseline, and compartment-specific joint space width (JSW) measures recorded at 72 
baseline and 4-year follow-up (Neumann et al. 2009). From the entire 4,796 OAI participants (9,592 73 
knees), a total of 3,178 participants (5,187 knees) had KL grade 1-3. Of these, 3,075 knees from 74 
1,961 participants (58% female) were included in the current analysis (Table 1) (Additional File 2) 75 
Evaluation of knee extensor muscle strength 76 
Peak isometric KE strength was measured in Newtons at baseline using the “Good Strength Chair” 77 
(Metitur Oy, Jyvaskyla, Finland) as described previously (Culvenor et al. 2015). Torque per body 78 
weight (Nm/kg) was calculated using the lever arm length recorded at the strength assessment. In 79 
the absence of previously defined thresholds, we used sex-specific tertiles of torque per body weight 80 
to create three equal sized groups based on sex-specific KE torque (lowest, middle, highest group). 81 




Medial and lateral radiographic JSW was measured at baseline and follow-up with customized 83 
software at fixed locations, based on a range from X=0% to X=100% of the distal femur mediolateral 84 
width (central release 0.6) (Ornetti et al. 2009). For the current analysis, baseline fixed-location 85 
measures in the centre of the medial (X=22.5%) and lateral compartment (X=80%) were used, as 86 
these were shown to display high sensitivity to change in KOA (Wirth et al. 2013).  87 
Radiographic progression was defined as a JSW reduction of ≥0.7mm. This cut-off has been shown to 88 
provide the best predictive value for detecting progression at 3-year follow-up and was further 89 
validated using Bland/Altman method to calculate the smallest detectable change (Bruyere et al. 90 
2005, Ornetti et al. 2009). In these studies, a minimal JSW (mJSW) reduction of ≥0.7mm in OAI 91 
control participants showed a minimal probability (≤10%) of change due to measurement error over 92 
a 12-month period (Ornetti et al. 2009). In the absence of a threshold for fixed location measures, 93 
we used the 0.7mm threshold previously determined for mJSW; hence subjects with a reduction of 94 
JSW ≥0.7mm in either the medial (X=22.5%) or lateral (X=80%) compartment were defined as 95 
progressors. 96 
Frontal plane knee alignment 97 
Frontal plane knee alignment was assessed at baseline using the FTA, as previously described 98 
(release 0.6) (Iranpour-Boroujeni et al. 2014)(Additional File 1), which was more frequently recorded 99 
in the OAI database than the full-limb hip-knee-ankle (HKA) angle. More negative values indicate 100 
greater varus alignment. The FTA method has high intra- and inter-reader reproducibility (ICC ≥0.98) 101 
(Iranpour-Boroujeni et al. 2014)) and is highly correlated with the HKA angle, having similar ability in 102 
predicting 2-year tibiofemoral cartilage loss (Iranpour-Boroujeni et al. 2014). For the current study, a 103 
HKA angle was derived from the FTA using sex-specific conversion formulae (Iranpour-Boroujeni et 104 
al. 2014). Alignment categories were valgus (HKA ≥+2ᵒ), varus (HKA ≤-2ᵒ), and neutral (HKA <±2ᵒ 105 





To adjust for correlations between limbs within each subject and to assess the risk of radiographic 108 
progression in subjects with lower KE torque, we used Poisson regression models with generalized 109 
estimating equations. An independent working correlation structure was used. To explore the effect 110 
of lowest (or middle) vs. highest KE torque (i.e., lowest vs. highest; middle vs. highest) on the risk of 111 
progression, we estimated the relative risk (RR) and 95% confidence intervals (CI) of KOA 112 
progression. 113 
For the primary analysis, KOA progression was defined as occurring in either the medial or lateral 114 
tibiofemoral compartment and risk of progression was stratified by knee alignment (neutral vs. 115 
malaligned [i.e., either varus or valgus]) as per Sharma et al. (2003). Analyses were adjusted for 116 
confounders, selected using clinical reasoning and literature review, and portrayed in direct acyclic 117 
graphs to minimise overadjustment and collider stratification bias. Analyses were adjusted for age, 118 
sex, BMI, KL grade, and baseline pain using knee-specific Western Ontario and McMaster 119 
Universities Osteoarthritis Index (WOMAC) pain score (0-100). Older age, sex and knee-related pain 120 
increase risk of both KE weakness and KOA progression (Hunter 2009), while BMI and baseline KL 121 
grade directly influence KOA progression as well as being on a causal pathway via muscle weakness 122 
(i.e., BMI can influence KL grade which increases pain, leading to muscle weakness). We also 123 
adjusted for alignment (continuous variable to account for differences within each alignment 124 
category) as per Amin et al (2009). 125 
For secondary analyses, we calculated the compartment-specific risk of progression stratified by sex 126 
and knee alignment categories (neutral, varus, valgus). Knees without JSW reduction in either 127 
compartment were considered as non-progressors and used as controls. Analyses were adjusted as 128 
per primary analysis (excluding sex) and performed using SPSS (v22.0; IBM Corp., Armonk, NY). 129 
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RESULTS 160 
Women had 35% lower absolute muscle force (N) and 27% lower torque per body weight (Nm/kg) 161 
than men (Table 1). Approximately half of all knees had neutral alignment (52%), while 38% and 10% 162 
had varus and valgus malalignment, respectively (Table 1). 163 




Table 1: Baseline characteristics of the sample# 165 





Knees, n (% of total) 3,075 (100) 1,825 (59.3) 1,250 (40.7) 
Age, years 62.2 (8.8) 62.4  (8.7) 61.9 (9) 
BMI, kg/m2 29.4 (4.7) 29.5 (5.1) 29.4 (4) 
Height, m 1.68 (0.09) 1.63 (0.06) 1.76 (0.06) 
Weight, kg 83.7 (16) 78.0 (14.5) 92.0 (14.3) 
WOMAC pain, 0-100 12.9 (16.9) 14.2 (17.9) 11.0 (15.0) 
WOMAC physical function,  
0-100 13.1 (16.0) 16.0 (17.1) 10.6 (13.9) 
WOMAC stiffness, 0-100 20.4 (20.3) 22.1 (21.1) 17.7 (18.7) 
KL grade    
1, n (% of category) 616 (20) 367 (20) 249(20) 
2, n (% of category) 1,650 (54) 1,029 (56) 621 (50) 
3, n (%of category) 809 (26) 429 (24) 380 (30) 
Knee extensor strength 
(Newtons) 338.7 (129.4) 277.7 (92.7) 427.5 (23.7) 
Knee extensor torque per 
body weight, Nm/kg 1.2 (0.4) 1.1 (0.4) 1.5 (0.5) 
Frontal plane alignment, ᵒ -1.1 (2.5) -0.2 (2.3) -2.5 (2.2) 
Alignment     
Neutral, n (% of category) 1,609 (52) 1,183 (65) 426 (34) 
Varus, n (% of category) 1,159 (38) 374 (20) 785 (63) 
Valgus, n (%of category) 307 (10) 268 (15) 39 (3) 
# Except where indicated otherwise, values are mean (SD). 
n: number of knees except where indicated otherwise 
BMI, body mass index; KL, Kellgren/Lawrence; WOMAC, Western Ontario and McMaster Universities 
Osteoarthritis Index 
 166 
In the primary analysis, 1,431 knees (46.5%) displayed radiographic progression. 670 knees (21.8%) 167 
and 521 knees (17%) displayed medial and lateral progression, respectively; while 240 knees (7.8%) 168 
displayed progression in both compartments, and 1,644 (53.5%) no progression in either 169 
compartment. Being in the lowest or middle KE torque group increased the risk of KOA progression 170 
in either compartment for neutrally aligned knees in the unadjusted analysis (lowest KE torque 171 




(Table 2). In malaligned knees, KE torque was not significantly associated with radiographic 173 
progression (Table 2). 174 







Progressors, n (%) Crude RR (95% CI) Adjusted¥ RR (95% CI) 
Neutral 
alignment 
Low 226 (33) 1.16 (1.01, 1.36) 
1.03 
(0.78, 1.40) 
Middle 241 (36) 1.18 (1.02, 1.37) 
1.12 
(0.96, 1.30) 
High 209 (31) 1.00 1.00 
     
Malalignment# 
Low 253(33) 1.13 (0.99, 1.28) 
1.00 
(0.87, 1.14) 
Middle 256 (34) 1.05 (0.93, 1.20) 
0.99 
(0.86, 1.12) 
High 246 (33) 1.00 1.00 
*RR: relative risk; 95% CI = 95% confidence interval 
¥ Adjusted for baseline Kellgren/Lawrence grade, baseline WOMAC pain, age, body mass index, sex, and 
alignment. 





In secondary analyses, female knees without malalignment with the lowest KE torque had increased 178 
risk of radiographic progression in the lateral compartment compared to knees with the highest KE 179 
torque, both before and after adjustment (RRadj: 1.4 [95%CI 1.0, 1.8]). In contrast, KE torque did not 180 
significantly increase the risk of radiographic medial or lateral compartment progression in female 181 
knees with valgus or varus malalignment. Knee extensor torque also did not show any significant 182 
effect on the likelihood of KOA progression in men, regardless of the compartment and alignment 183 
(Table 3). However, due to the very low number of men with valgus malalignment (n=39), it was not 184 
possible to perform analyses in male knees with valgus. 185 




Table 3: Risk of radiographic progression by sex-specific extensor torque, stratified by sex and knee 187 
alignment 188 
 
  WOMEN 




    
Progressors 









Low 92 (33) 1.23 (0.93, 1.62) 
0.97  





Middle 102(36) 1.23 (0.94, 1.60) 
1.09  





High 86 (31) 1.00 1.00 73 (29) 1.00 1.00 
Valgus  
alignment# 
Low 17 (32) 0.89  (0.46, 1.72) 
0.69  
(0.33, 1.44) 48 (37) 
0.99 
 (0.73, 1.35) 
0.85 
(0.61, 1.17) 
Middle 21 (40) 1.12  (0.62, 2.01) 
0.99  
(0.55, 1.79) 43 (33) 
0.90  
(0.67, 1.24)  
0.87  
(0. 63, 1.20) 
High 15 (28) 1.00 1.00 38 (29) 1.00 1.00 
Varus  
alignment# 
Low 50 (36) 1.31  (0.94, 1.84) 
1.18  





Middle 44 (32) 1.18  (0.83, 1.67) 
1.18 





High 44 (32) 1.00 1.00 21 (30) 1.00 1.00 
  MEN 
Neutral  
alignment 
Low 44 (35) 1.02  (0.70, 1.49) 
0.97 





Middle 42 (34) 1.08  (0.75, 1.54) 
1.08 





High 39 (31) 1.00 1.00 39 (30) 1.00 1.00 
Valgus 
alignment# 
Low 1 (12) NA NA 5 (33) NA NA 
Middle 6 (76) NA NA 7 (46) NA NA 
High 1 (12) NA NA 3 (20) NA NA 
Varus 
alignment# 
Low 105 (34) 1.26 (0.96, 1.58) 
1.04  





Middle 100 (33) 1.06 (0.84, 1.34) 
0.92  





High 101 (33) 1.00 1.00 62 (38) 1.00 1.00 
RrelativeRR: relative risk; 95% CI = 95% confidence interval 
¥ Adjusted for baseline Kellgren/Lawrence grade, baseline WOMAC pain, age, body mass index, and alignment. 
* Percentage indicates progressors in the alignment category 






This is the first study to investigate the impact of KE weakness on the compartment- and sex-specific 191 
risk of radiographic KOA progression in the context of variation in frontal plane knee alignment. Our 192 
results from >3,000 knees suggest that lower KE torque is generally not associated with subsequent 193 
tibiofemoral radiographic progression, particularly when accounting for age, sex, BMI, radiographic 194 
severity and pain. However, compartment- and sex-specific analyses revealed that lower KE torque 195 
was associated with lateral compartment progression in women with neutrally aligned knees (before 196 
and after adjustment). These results identify a potentially important clinical phenotype and highlight 197 
that KE muscle weakness may be an important risk factor for disease progression specifically in 198 
women without knee malalignment. 199 
The findings of our primary analysis in neutral and malaligned knees do not confirm previous data 200 
from a smaller number of knees (n=228) in the Mechanical Factors in Arthritis of the Knee (MAK) 201 
cohort that found KE weakness had a significant protective effect on KOA progression in malaligned 202 
knees (Sharma et al. 2003). In contrast, our results showed effect sizes of similar magnitude between 203 
neutral and malaligned knees, and that higher KE strength tended to be more (but not statistically 204 
significant) protective of KOA progression, as recently observed in a systematic review (Culvenor et 205 
al. 2017b). Our results extend this recent systematic review and meta-analysis that did not observe a 206 
significant association between KE weakness and tibiofemoral structural deterioration (Culvenor et 207 
al. 2017b) by accounting for variations in knee alignment and evaluating the sex-specific effect on 208 
medial and lateral compartment progression. 209 
In stratifying by knee alignment categories in men and women, we observed that KE weakness 210 
increased the risk of (lateral) KOA progression in women with neutral knee alignment (before and 211 




joint progression when KE weakness is present may be explained by women having a lower absolute 213 
strength capacity, and thereby potentially being closer to a threshold below which the risk of OA 214 
progression increases (Culvenor et al. 2017b). Moreover, KOA has a higher prevalence in women 215 
where biochemical differences (i.e. hormonal) are thought to play a role in the development and 216 
progression of disease, and the ability of KE muscle fibres to generate force diminishes with greater 217 
BMI in women, but not in men (Culvenor et al. 2017a). 218 
Knee malalignment represents a well-established risk factor for KOA progression (Felson and Kim 219 
2007), and as hypothesized, the local mechanical environment appears to influence the relationship 220 
between KE torque and KOA progression demonstrated in previous work (Culvenor et al. 2016, 221 
Øiestad et al. 2015). It appears that once malalignment is present, the lack of KE torque has little 222 
effect on the risk of KOA progression. This is supported by the observation that 52% of all knees with 223 
malalignment displayed radiographic progression whereas only 42% did in the neutral group. In 224 
neutral aligned knees, in contrast, muscle weakness appears to play a role in subsequent 225 
progression, particularly in women, and therefore optimizing muscle impairments provides a 226 
potential avenue to help modify the risk of progression in women with neutral knee alignment.  227 
Our findings somewhat contrast those of Amin et al. (2009) who observed no influence of sex-228 
specific tertiles of KE torque on MRI-assessed medial or lateral cartilage lesion progression in knees 229 
without varus malalignment (i.e., <5° varus). The inclusion of valgus knees in the ‘neutral aligned’ 230 
group, the lack of stratification by sex, the different definition of progression (semi-quantitative MRI-231 
based cartilage lesion scores) and the shorter observation period (15 to 30 months follow-up) may 232 
explain these differences and the lack of sensitivity in this previous study (Amin et al. 2009). Our 233 
findings of lateral compartment radiographic progression in female neutrally aligned knees may be 234 
the result of the differences in gait kinematics between sexes. Women with normal alignment have a 235 
larger knee abduction angle, hip adduction and internal rotation during gait compared to men with 236 




internal knee load towards the lateral compartment and has previously been associated with lateral 238 
KOA (Weidow et al. 2006). Women with muscle weakness therefore potentially have a higher risk of 239 
KOA progression in the lateral compartment due to the absence of muscle stability driving abnormal 240 
biomechanical load. Studies estimating knee internal contact forces are necessary in order to 241 
confirm this hypothesis. 242 
Limitations of our study include the estimation of mechanical alignment from the FTA. However, a 243 
strong correlation between FTA and HKA suggests that similar results would occur irrespective of 244 
alignment assessment approach (Iranpour-Boroujeni et al. 2014). Despite the large study sample of 245 
OAI participants, we were unable to complete evaluations of the influence of KE weakness in men 246 
with valgus alignment due to the small number of men with knee valgus. The relatively small number 247 
of progressors in some other strata limits generalizability and means interpretation should be made 248 
with some caution. Second, to determine disease progression in both medial and lateral 249 
compartment we used the JSW threshold of 0.7mm. This cut-off has been determined from test-250 
retest measurements of medial compartment mJSW (Ornetti et al. 2009). However, since the mJSW 251 
can only be measured in the medial (and not the lateral) compartment, and because no cut-off has 252 
been established for fixed-location JSW measures, we decided to apply a cut-off of 0.7mm for fixed 253 
location measures in the current study. Overall, generalizability of the results may be limited by cut-254 
offs used to determine strata (i.e. muscle torque tertiles, alignment and radiographic disease 255 
progression). In addition, considering the slow rate of progression that characterizes KOA, a longer 256 
follow up period (>4 years) should be considered to improve the estimates of the risk of OA 257 
radiographic progression associated with KE deficit.  Finally, it is important to acknowledge that, in 258 
our secondary analysis, we did not account for multiple tests, but the analyses stratified by sex and 259 
compartment support the trends seen in the primary analyses. 260 
Targeting the right patient with the right treatment constitutes a priority in KOA care (Dell’Isola et al. 261 




progression in women with neutral knee alignment. Exercise therapy, including muscle 263 
strengthening and neuromuscular exercises, is the first line treatment for patients with KOA 264 
(Fernandes et al. 2013, National Institute of Clinical Excellence 2014). International guidelines 265 
indicate that these interventions need to be specifically tailored to the individual (Nelson et al. 266 
2014). Results of our study suggest that including exercises aimed to increase KE torque may be 267 
particularly beneficial for structural outcomes in females with neutral alignment, in addition to 268 
optimizing functional capacity and reducing symptoms in all patients with KOA (Lange et al. 2008)  269 
In summary, in the tibiofemoral joint of men and women as a whole, lower KE torque is generally 270 
not associated with KOA progression over four years, particularly after adjustment for other risk 271 
factors. However, in unravelling this relationship further, this study has identified an important 272 
subset of women (without malalignment), in which KE weakness was associated with (lateral) 273 
tibiofemoral progression. No relationship between KE weakness and compartment-specific 274 
progression was observed in men. Optimizing muscle impairments may help modify the risk of 275 
progression in women with neutral knee alignment. 276 
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